Labshake search
Citations for TargetMol :
1 - 31 of 31 citations for 6H Purin 6 one 2 amino 8 chloro 1 9 dihydro since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2023Quote: ... and 5-(3-Bromophenyl)-1,3-dihydro-2H-benzofuro[3,2-e]-1,4-diazepin-2-one (5-BDBD) (cat. no. T22518, TargetMol, Wellesley Hills, Massachusetts, USA) were dissolved in stock solutions and then diluted into ACSF at specified concentrations (50 µM IVM ...
-
bioRxiv - Cell Biology 2021Quote: ... a 10% CCK-8 solution (Targetmol, C0005) in medium was added and re-incubated for 2 h ...
-
bioRxiv - Biochemistry 2021Quote: ... Approval drug library (L1000) and Nisoldipine power (Cas # 63675-72-9) were purchase from Targetmol. Dehydro Nisoldipine (Cas #103026-83-1 ...
-
bioRxiv - Systems Biology 2022Quote: ... and everolimus (Targetmol, 159351-69-6). The cells were then incubated for 72 hrs ...
-
bioRxiv - Molecular Biology 2023Quote: ... Remodelin (MCE or TargetMol, 1622921-15-6) was administered once every two days by oral gavage at 80 mg/kg body weight for 4 weeks ...
-
bioRxiv - Microbiology 2023Quote: ... nirmatrelvir (cat. T9351, CAS No. 2628280-40-8) from Targetmol.
-
bioRxiv - Systems Biology 2022Quote: ... AKT1-2 inhibitor MK-2206 (Targetmol, 1032350-13-2), and everolimus (Targetmol ...
-
bioRxiv - Biochemistry 2021Quote: ... The BC-1471 compounds (TargetMol, CAS 896683-84-4 and CAS 896683-78-6) were also evaluated with STAMBPJAMM under identical conditions with a final concentration of 1 μM ...
-
bioRxiv - Cancer Biology 2023Quote: ... one library containing FDA approved drugs that can penetrate through blood-brain barrier (269 drugs from TargetMol, Massachusetts, USA), and one library containing drugs targeting the possible targets identified in omics analysis (58 drugs from MedchemExpress ...
-
bioRxiv - Biophysics 2022Quote: ... Ara-C (2 mM, TargetMol, T1272) was added to the medium to inhibit neural stem cell proliferation ...
-
bioRxiv - Systems Biology 2022Quote: ... including lapatinib (Targetmol, 231277-92-2), AKT1-2 inhibitor MK-2206 (Targetmol ...
-
bioRxiv - Molecular Biology 2023Quote: Cell counting kit 8 (CCK8) experiment for cell viability assay were performed using the CCK8 Kit (TargetMol, MA, USA). After a treatment ...
-
bioRxiv - Biophysics 2022Quote: ... and 2 mg/ml doxycycline (TargetMol, T1687). On day 1 ...
-
bioRxiv - Cancer Biology 2024Quote: Cells were seeded into 96-well culture plates at the density of 3000 cells per well after transfected with siRNA oligos and cultured for 5 days with the viability measured daily using the Cell Counting Kit-8 (CCK8) (TargetMol) according to the manufacturer’s protocol ...
-
bioRxiv - Cell Biology 2021Quote: WIN 55,212-2 mesylate was purchased from TargetMol (T4458). Stock solutions were prepared using 100% dimethyl sulfoxide (DMSO ...
-
bioRxiv - Cancer Biology 2019Quote: ... cells were pre-treated with Afatinib (2 μM; T2303, TargetMol) or LY2157299 (10 μM ...
-
bioRxiv - Cancer Biology 2023Quote: ... 1% NP-40) supplemented with 1% protease inhibitor cocktail (C0001, TargetMol). Immunoprecipitation was performed using Anti-FLAG M2 Magnetic Beads (M8823 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 1 μM of each drug (TargetMol.USA) were added ...
-
bioRxiv - Molecular Biology 2020Quote: Cell pellets as described above were lysed in RIPA lysis buffer (50 mM Tris, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100, protease cocktail [TargetMol], and 1 mM PMSF) at 4°C for 10 minutes ...
-
bioRxiv - Molecular Biology 2020Quote: Cells were washed with PBS and lysed by incubation on ice for 10 min with RIPA lysis buffer (50 mM Tris, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100, protease cocktail [C0001, Targetmol], and 1 mM PMSF). The proteins were resolved by SDS/PAGE and transferred to 0.22 um nitrocellulose membrane (PALL) ...
-
bioRxiv - Biochemistry 2021Quote: ... STAM1 (STAM1:DUB = 5:1) or BC-1471 (TargetMol) at indicated concentrations ...
-
bioRxiv - Molecular Biology 2023Quote: ... 1x protease inhibitor cocktail (TargetMol, 1 mL/100 mL suspension), 10 μM MCH and 10 μg/mL Nb35(only for MCHR2) ...
-
bioRxiv - Biophysics 2021Quote: ... supplemented with Protease Inhibitor Cocktail (TargetMol, 1 mL/ 100 mL suspension). ScFv16 was applied to stabilize GHRP-6–ghrelin receptor–Gq complex ...
-
bioRxiv - Biochemistry 2022Quote: ... supplemented with Protease Inhibitor Cocktail (TargetMol, 1 mL/100 mL suspension). The lysate was incubated for 1 h at room temperature and complex from membranes solubilized by 0.5% (w/v ...
-
bioRxiv - Molecular Biology 2023Quote: ... T-5224 (120 mg/kg body weight, TargetMol, 530141-72-1) was injected intraperitoneally every three days for 4 weeks.
-
bioRxiv - Biochemistry 2023Quote: ... supplemented with Protease Inhibitor Cocktail (TargetMol, 1 mL/100 mL suspension). The lysate was incubated for 1 h at room temperature and then solubilized by 0.5% (w/v ...
-
bioRxiv - Genomics 2023Quote: ... 1/100 volume of protease inhibitor cocktail (C0001, TargetMol, Boston, USA), 0.15% Triton X-100) ...
-
bioRxiv - Cancer Biology 2023Quote: Venetoclax (1 mL*10 mM in DMSO) and powdered compound were purchased from TargetMol. Fedratinib (1 mL*10 mM in DMSO ...
-
bioRxiv - Biophysics 2021Quote: ... 1mM dithiothreitol (DTT) and 1×ethylene diamine tetraacetic acid (EDTA) free protease inhibitor cocktail (TargetMol). The suspension was frozen in liquid nitrogen and stored at −80°C for further use.
-
bioRxiv - Neuroscience 2023Quote: ... 2-(3-(4-chloro-3-fluorophenyl)-5-ethyl-1H-1,2,4-triazol-1-yl)-N-(3,5-di-chlorobenzyl)acetamide (MR-L2) was from Targetmol Chemicals ...
-
bioRxiv - Cell Biology 2021Quote: ... cells were treated with specific concentrations of geroprotective agents (ABT-263 at 1 μM, ABT-737 at 10 μM, Selleckchem; GSE at 0.75 μg/ml, or PCC1 at 50 μM, TargetMol) for 72 h ...